Furihata Makoto, Ono Yuko, Ichikawa Kazuhito, Tomita Shigeki, Fujimori Takahiro, Kubota Keiichi
Department of Surgical and Molecular Pathology, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Shimotsuga, Tochigi 321-0293, Japan.
Oncol Rep. 2005 Aug;14(2):353-6.
Dendritic cells (DCs) are very potent antigen-presenting cells that play an essential role in the primary immune response to carcinoma. Tumor-infiltrating DCs have been found to be clinically significant in many human malignancies such as colon, stomach, lung, breast and hepatic carcinoma. However, clinical significance of activated and/or immature DCs in gallbladder carcinoma has not been reported yet. Thus, we immunohistochemically evaluated CD83+ DCs and CD1a+ DCs of cancerous and peritumoral area in 29 cases of resected gallbladder. In the results, CD83(+) DCs were significantly fewer in cancerous area than that in peritumoral area (1.55/hpf vs. 4.26/hpf, p=0.0047), but the numbers of CD1a(+) DCs did not differ (p=0.075). In addition, we defined a CD83 index as CD83(+) DCs/(CD83(+) DCs plus CD1a(+) DCs), and analyzed the relationship between CD83 index and clinicopathological factors. The group with a higher CD83 index (index >0.316) showed significantly better prognosis than the group with a lower CD83 index (index < or =0.316) in cancerous and peritumoral areas. In conclusion, we suggest the importance of tumor-infiltrating CD83(+) DCs as a useful prognostic factor for patients with gallbladder carcinoma.
树突状细胞(DCs)是非常有效的抗原呈递细胞,在对癌的初次免疫反应中起重要作用。已发现肿瘤浸润性DCs在许多人类恶性肿瘤如结肠癌、胃癌、肺癌、乳腺癌和肝癌中具有临床意义。然而,活化和/或未成熟DCs在胆囊癌中的临床意义尚未见报道。因此,我们采用免疫组织化学方法评估了29例切除胆囊的癌组织和瘤周组织中CD83+ DCs和CD1a+ DCs的情况。结果显示,癌组织中CD83(+) DCs明显少于瘤周组织(1.55/hpf对4.26/hpf,p = 0.0047),但CD1a(+) DCs的数量无差异(p = 0.075)。此外,我们将CD83指数定义为CD83(+) DCs/(CD83(+) DCs加CD1a(+) DCs),并分析了CD83指数与临床病理因素之间的关系。在癌组织和瘤周组织中,CD83指数较高的组(指数>0.316)的预后明显优于CD83指数较低的组(指数≤0.316)。总之,我们认为肿瘤浸润性CD83(+) DCs作为胆囊癌患者有用的预后因素具有重要意义。